We are live on ! Find out more
VYNE icon

VYNE Therapeutics
VYNE

105 hedge funds and large institutions have $132M invested in VYNE Therapeutics in 2020 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 25 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 25

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.04% less ownership

Funds ownership: 0.7% → 0.66% (-0.04%)

1% less funds holding

Funds holding: 106 → 105 (-1)

5% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 20

17% less capital invested

Capital invested by funds: $160M → $132M (-$28M)

Holders
105
Holders Change
-1
Holders Change %
-0.94%
% of All Funds
2.12%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
19
Increased
33
Reduced
25
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.64M
2
State Street
State Street
Massachusetts
+$749K
3
6CM
683 Capital Management
New York
+$679K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$594K
5
Northern Trust
Northern Trust
Illinois
+$442K

Top Sellers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
-$2.95M
2
Millennium Management
Millennium Management
New York
-$2.16M
3
CCM
CAAS Capital Management
New York
-$2.05M
4
SI
Sofinnova Investments
California
-$1.26M
5
BBVA
Banco Bilbao Vizcaya Argentaria
Spain
-$1.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
SFI
26
Susquehanna Fundamental Investments
Pennsylvania
$428K – – –
Ameriprise
27
Ameriprise
Minnesota
$391K -$93.9K -805 -20%
SSA
28
Schonfeld Strategic Advisors
New York
$368K -$255K -2,189 -42%
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$365K +$95.8K +821 +37%
Point72 Asset Management
30
Point72 Asset Management
Connecticut
$352K +$344K +2,949 New
Two Sigma Advisers
31
Two Sigma Advisers
New York
$344K +$94.4K +809 +39%
Connor, Clark & Lunn Investment Management (CC&L)
32
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$332K +$324K +2,781 New
State of Wisconsin Investment Board
33
State of Wisconsin Investment Board
Wisconsin
$286K +$279K +2,390 New
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$243K +$4.43K +38 +2%
AllianceBernstein
35
AllianceBernstein
Tennessee
$231K -$118K -1,015 -34%
VF
36
Virtu Financial
New York
$212K +$207K +1,770 New
CL
37
CSS LLC
Illinois
$209K – – –
PTP
38
Platform Technology Partners
New York
$198K +$193K +1,657 New
TRCT
39
Tower Research Capital (TRC)
New York
$196K +$168K +1,438 +698%
Wells Fargo
40
Wells Fargo
California
$181K -$10K -86 -5%
HighTower Advisors
41
HighTower Advisors
Illinois
$175K +$24.7K +212 +17%
Commonwealth Equity Services
42
Commonwealth Equity Services
Massachusetts
$172K – – –
PPA
43
Parametric Portfolio Associates
Washington
$167K +$63.8K +547 +64%
Jane Street
44
Jane Street
New York
$164K +$21.7K +186 +16%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$162K – – –
UBS Group
46
UBS Group
Switzerland
$155K -$15.6K -134 -9%
Goldman Sachs
47
Goldman Sachs
New York
$151K -$17.9K -153 -11%
AIG
48
American International Group
New York
$144K +$35.1K +301 +33%
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$136K +$25.6K +219 +24%
FIM
50
Fernwood Investment Management
Massachusetts
$132K +$29.2K +250 +29%
1
2
3 4 5

VYNE Hedge Fund Activity: Q3 2020 in Review

105 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in VYNE Therapeutics (VYNE) for Q3 2020, worth a combined $132M — down 17% from $160M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of VYNE and 19 opened new positions — a net loss of 1 holder — while 25 trimmed existing stakes and 33 added.

The largest buyer was BlackRock, adding an estimated $2.64M. The largest seller was Vivo Capital, cutting an estimated $2.95M.

  • 105 institutional investors held VYNE Therapeutics (VYNE) as of Q3 2020, down from 106 in Q2 2020.
  • Funds reported $132M of VYNE Therapeutics stock for Q3 2020, down 17% quarter-over-quarter.
  • 19 funds opened new VYNE Therapeutics positions in Q3 2020 and 20 closed out, a net change of -1 holder.
  • The largest VYNE Therapeutics buyer in Q3 2020 was BlackRock, an estimated $2.64M added.
  • The largest VYNE Therapeutics seller in Q3 2020 was Vivo Capital, an estimated $2.95M sold.

Based on aggregated 13F filings for Q3 2020.